Top Stories
-
The way SARS-CoV-2 mutates in immunocompromised patients to escape Paxlovid could help chemists design better drugs that are more difficult for the virus to sidestep.
Topic
-
Columbia researchers have found why babies are susceptible to repeated bouts of common respiratory infections—but also have a unique weapon to fight off new pathogens that healthy adults lack.
Topic
-
Columbia University experts explain the mosquito-borne illness and its treatments.
Topic
-
Patients with mpox who were treated with the antiviral drug tecovirimat had similar outcomes regardless of HIV status, find researchers at Columbia University and Weill Cornell Medicine.
Topic
Latest News
- October 15, 2020
Flu season is coming—how will the influenza vaccine be different in the era of COVID-19? Columbia’s David Buchholz, MD, explains.
Topic
- October 15, 2020
Outbreaks of SARS-CoV-2 may become a regular occurrence depending on the risk of reinfection, vaccine availability and efficacy, and interactions with other viruses, Mailman researchers say.
Topic
- October 12, 2020
Moms with COVID-19 who take basic precautions rarely pass the virus to their newborns, even if breastfeeding and rooming together, finds a new study at Columbia University and NewYork-Presbyterian.
Topic
- October 5, 2020
Video lectures and virtual labs from the Mailman School of Public Health's two-day "COVID-19 From Virus to Vaccine" course in late August are now online and available to all.
Topic
- September 24, 2020
As members of a Testing Innovation Council, Mailman scientists helped evaluate diagnostic technologies to support the city’s need for rapid testing.
Topic
- September 21, 2020
Months after recovering from a mild case of COVID-19, even healthy young adults are experiencing memory problems, fatigue, mood changes, and other neurological and psychiatric issues.
Topic
- September 8, 2020
Experts on convalescent plasma discuss why randomized clinical trials of the treatment in COVID-19 patients are more important than ever.
Topic
- September 4, 2020
After the pandemic forced many scientists to put studies on pause, VP&S and other CUIMC researchers are back on campus with a renewed sense of purpose.
Topic
- September 3, 2020
Mailman's ICAP has harnessed the partnerships made in combating HIV in Africa, Asia, and the Americas to meet the threat of COVID-19.
Topic
- September 3, 2020
Columbia psychiatrists are developing a financial wellness program to help New Yorkers buffer the mental health impact of unemployment, financial loss, and eviction.
Topic
